Baxter Healthcare Corporation vs Samsung Bioepis Co. Ltd.: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 209 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Samsung Bioepis Co. Ltd..

Baxter Healthcare Corporation: 0 warning letters, 209 recalls, 0 approval records, 0 Form 483s.

Samsung Bioepis Co. Ltd.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Baxter Healthcare Corporation — Warning letters0

Samsung Bioepis Co. Ltd. — Warning letters0

Baxter Healthcare Corporation — Recalls209

Samsung Bioepis Co. Ltd. — Recalls0

Baxter Healthcare Corporation — Approval records0

Samsung Bioepis Co. Ltd. — Approval records0

Baxter Healthcare Corporation — Form 483s0

Samsung Bioepis Co. Ltd. — Form 483s1

Timeline

Baxter Healthcare Corporation

Most recent FDA action: August 19, 2026

Full history →

Samsung Bioepis Co. Ltd.

Most recent FDA action: November 22, 2024

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs Samsung Bioepis Co. Ltd.: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-samsung-bioepis-co-ltd

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗